Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Providing Clarity in a Noisy DTC Hearing Aid Market: The Growth of InnerScope Hearing Technologies Inc. (INND)

37.5 million Americans report some degree of hearing impairment each year, many of which can’t afford the high out-of-pocket costs of prescription hearing aids InnerScope offers a comprehensive portfolio of affordable products that do not require a doctor’s prescription In recent months, InnerScope has made accretive acquisitions and more than tripled its staff, further cementing […]

Friendable Inc. (FDBL) Reaches over 111,000 Artist Sign-Ups; Gets Featured by XLIVE Publication

Following the acquisition of online music distribution company Artist Republik, Friendable has created a 360-degree platform that nurtures independent artists without the constraints of a label Fan Pass Live Artist Pro-Services provide artists more options for branding and exposure The company has launched merchandise for Spring 2022 for artists and fans, releasing new styles that […]

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Expands E-Commerce Offering to Include Delivery Across Ottawa and Toronto, Ontario

E-commerce and third-party delivery apps will use brick-and-mortar retail locations as fulfillment centers and marketing hubs to boost shopper traffic on the digital platform PlantX is positioned to disrupt the global plant-based alternatives market, which is expected to grow to $162 billion over the next years Currently offering over 5,000 plant-based products on its platform, […]

Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) Announces Next Segment in Far-Reaching ‘Psychedelics for Alcoholism’ Series

Clearmind Medicine (CSE: CMND) (FSE: CWY0), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics, has announced the fifth webinar in its Psychedelics for Alcoholism series. This segment is titled “Psychedelics for Alcoholism, Q&A with Clearmind Management.” Scheduled for March 30, 2022, this insightful event will feature Clearmind CEO Adi Zuloff-Shani and […]

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Launches New European Routing Nodes, Now Providing Nine Active Nodes on Lightning Network

LQwD has recently deployed additional routing nodes in Europe, namely in Italy, Sweden, Ireland, England and France Since the US-West deployment in November 2021, LQwD has seen 157 nodes interconnected with more than 158 transaction channels over 10 Bitcoin through all channels Arcane Research predicts that there will be as many as 700 million Lightning […]

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Prepares Summer Gold Exploration Program in Ontario, Amid European War Era Instability

StraightUp Resources is a mining acquisition and exploration company with flagship properties in Ontario, Canada, and an expanding international footprint Following on the acquisition of aerial digital magnetic survey data last year for its flagship properties, the company is preparing a summer work program that will include analysis of its data, identification of key geological […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces First Phase of Epilepsy Research Using DehydraTECH(TM)-CBD

Lexaria’s patented DehydraTECH(TM) technology provides faster delivery times, increases bioavailability, increases brain absorption, improves drug potency, reduces administration costs, and masks unwanted flavors The epilepsy research will compare the FDA-approved Epidiolex(R) to the company’s proprietary DehydraTECH-CBD formulation The global cannabidiol (“CBD”) market had an estimated value of $2.7 billion in 2021 and is expected to […]

 

From Our Blog

SS Innovations International, Inc. (NASDAQ: SSII) CEO Outlines Growth Strategy as SSi Mantra Expands Robotic Surgery, Telesurgery, and Global Reach

November 6, 2026

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is seeing increased adoption of its SSi Mantra surgical robotic platform, with CEO Dr. Sudhir Srivastava telling The Motley Fool’s interviewer Rachel Warren that the company’s commercial growth reflects a combination of technological capabilities, clinical experience and affordability (https://ibn.fm/EJk05). During the interview, Srivastava […]

Rotate your device 90° to view site.